Presidential Panel: Costly Cancer Drugs Harm Care

Share this post

The panel recommends a series of actions to minimize the impact of drug costs on patients while also promoting value-based pricing of newer drugs.

This post was syndicated from WebMD Health. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply